{"data":[{"accessionNo":"0001950047-26-010273","issuerCik":"0001438533","issuerName":"TRAVERE THERAPEUTICS, INC.","ticker":"TVTX","personName":"ERIC DUBE","relationship":"Director, Officer","securityClass":"Common","broker":"Morgan Stanley Smith Barney LLC Executive Financial Services","unitsToSell":243735,"aggregateMarketValue":12983763.45,"unitsOutstanding":94261082,"approxSaleDate":"2026-10-15","exchange":"NASDAQ","filedAt":"2026-10-15","canonicalUrl":"https://xoomar.com/markets/stocks/tvtx"},{"accessionNo":"0001950047-26-009642","issuerCik":"0001438533","issuerName":"TRAVERE THERAPEUTICS INC","ticker":"TVTX","personName":"ERIC DUBE","relationship":"Director, Officer","securityClass":"Common","broker":"Morgan Stanley Smith Barney LLC Executive Financial Services","unitsToSell":108493,"aggregateMarketValue":6887135.64,"unitsOutstanding":94261082,"approxSaleDate":"2026-09-17","exchange":"NASDAQ","filedAt":"2026-09-17","canonicalUrl":"https://xoomar.com/markets/stocks/tvtx"},{"accessionNo":"0001950047-26-009625","issuerCik":"0001438533","issuerName":"TRAVERE THERAPEUTICS INC","ticker":"TVTX","personName":"PETER HEERMA","relationship":"Officer","securityClass":"Common","broker":"Morgan Stanley Smith Barney LLC Executive Financial Services","unitsToSell":8282,"aggregateMarketValue":525741.36,"unitsOutstanding":94261082,"approxSaleDate":"2026-09-17","exchange":"NASDAQ","filedAt":"2026-09-17","canonicalUrl":"https://xoomar.com/markets/stocks/tvtx"},{"accessionNo":"0001950047-26-009576","issuerCik":"0001438533","issuerName":"TRAVERE THERAPEUTICS INC","ticker":"TVTX","personName":"PETER HEERMA","relationship":"Officer","securityClass":"Common","broker":"Morgan Stanley Smith Barney LLC Executive Financial Services","unitsToSell":172717,"aggregateMarketValue":10796539.67,"unitsOutstanding":94261082,"approxSaleDate":"2026-09-16","exchange":"NASDAQ","filedAt":"2026-09-16","canonicalUrl":"https://xoomar.com/markets/stocks/tvtx"},{"accessionNo":"0001950047-26-009577","issuerCik":"0001438533","issuerName":"TRAVERE THERAPEUTICS INC","ticker":"TVTX","personName":"WILLIAM ROTE","relationship":"Officer","securityClass":"Common","broker":"Morgan Stanley Smith Barney LLC Executive Financial Services","unitsToSell":112850,"aggregateMarketValue":7054253.5,"unitsOutstanding":94261082,"approxSaleDate":"2026-09-16","exchange":"NASDAQ","filedAt":"2026-09-16","canonicalUrl":"https://xoomar.com/markets/stocks/tvtx"},{"accessionNo":"0001950047-26-009566","issuerCik":"0001438533","issuerName":"TRAVERE THERAPEUTICS INC","ticker":"TVTX","personName":"ERIC DUBE","relationship":"Director, Officer","securityClass":"Common","broker":"Morgan Stanley Smith Barney LLC Executive Financial Services","unitsToSell":195841,"aggregateMarketValue":12242020.91,"unitsOutstanding":94261082,"approxSaleDate":"2026-09-16","exchange":"NASDAQ","filedAt":"2026-09-16","canonicalUrl":"https://xoomar.com/markets/stocks/tvtx"},{"accessionNo":"0001950047-26-009488","issuerCik":"0001438533","issuerName":"TRAVERE THERAPEUTICS, INC.","ticker":"TVTX","personName":"JULA INRIG","relationship":"Officer","securityClass":"Common","broker":"Morgan Stanley Smith Barney LLC Executive Financial Services","unitsToSell":44674,"aggregateMarketValue":2939102.46,"unitsOutstanding":94261082,"approxSaleDate":"2026-09-15","exchange":"NASDAQ","filedAt":"2026-09-15","canonicalUrl":"https://xoomar.com/markets/stocks/tvtx"},{"accessionNo":"0001950047-26-009503","issuerCik":"0001438533","issuerName":"TRAVERE THERAPEUTICS, INC.","ticker":"TVTX","personName":"WILLIAM ROTE","relationship":"Officer","securityClass":"Common","broker":"Morgan Stanley Smith Barney LLC Executive Financial Services","unitsToSell":96198,"aggregateMarketValue":6328866.42,"unitsOutstanding":94261082,"approxSaleDate":"2026-09-15","exchange":"NASDAQ","filedAt":"2026-09-15","canonicalUrl":"https://xoomar.com/markets/stocks/tvtx"},{"accessionNo":"0001950047-26-009510","issuerCik":"0001438533","issuerName":"TRAVERE THERAPEUTICS, INC.","ticker":"TVTX","personName":"PETER HEERMA","relationship":"Officer","securityClass":"Common","broker":"Morgan Stanley Smith Barney LLC Executive Financial Services","unitsToSell":102190,"aggregateMarketValue":6723080.1,"unitsOutstanding":94261082,"approxSaleDate":"2026-09-15","exchange":"NASDAQ","filedAt":"2026-09-15","canonicalUrl":"https://xoomar.com/markets/stocks/tvtx"},{"accessionNo":"0001950047-26-009513","issuerCik":"0001438533","issuerName":"TRAVERE THERAPEUTICS, INC.","ticker":"TVTX","personName":"ERIC DUBE","relationship":"Director, Officer","securityClass":"Common","broker":"Morgan Stanley Smith Barney LLC Executive Financial Services","unitsToSell":95666,"aggregateMarketValue":6293866.14,"unitsOutstanding":94261082,"approxSaleDate":"2026-09-15","exchange":"NASDAQ","filedAt":"2026-09-15","canonicalUrl":"https://xoomar.com/markets/stocks/tvtx"},{"accessionNo":"0001950047-26-009520","issuerCik":"0001438533","issuerName":"TRAVERE THERAPEUTICS, INC.","ticker":"TVTX","personName":"ELIZABETH REED","relationship":"Officer","securityClass":"Common","broker":"Morgan Stanley Smith Barney LLC Executive Financial Services","unitsToSell":39576,"aggregateMarketValue":2603705.04,"unitsOutstanding":94261082,"approxSaleDate":"2026-09-15","exchange":"NASDAQ","filedAt":"2026-09-15","canonicalUrl":"https://xoomar.com/markets/stocks/tvtx"},{"accessionNo":"0001950047-26-009521","issuerCik":"0001438533","issuerName":"TRAVERE THERAPEUTICS, INC.","ticker":"TVTX","personName":"CHRISTOPHER CLINE","relationship":"Officer","securityClass":"Common","broker":"Morgan Stanley Smith Barney LLC Executive Financial Services","unitsToSell":50508,"aggregateMarketValue":3322921.32,"unitsOutstanding":94261082,"approxSaleDate":"2026-09-15","exchange":"NASDAQ","filedAt":"2026-09-15","canonicalUrl":"https://xoomar.com/markets/stocks/tvtx"},{"accessionNo":"0001950047-26-009523","issuerCik":"0001438533","issuerName":"TRAVERE THERAPEUTICS, INC.","ticker":"TVTX","personName":"SANDRA CALVIN","relationship":"Officer","securityClass":"Common","broker":"Morgan Stanley Smith Barney LLC Executive Financial Services","unitsToSell":5375,"aggregateMarketValue":353621.25,"unitsOutstanding":94261082,"approxSaleDate":"2026-09-15","exchange":"NASDAQ","filedAt":"2026-09-15","canonicalUrl":"https://xoomar.com/markets/stocks/tvtx"},{"accessionNo":"0001950047-26-009292","issuerCik":"0001438533","issuerName":"TRAVERE THERAPEUTICS INC","ticker":"TVTX","personName":"JEFFREY MECKLER","relationship":"Director","securityClass":"Common","broker":"Morgan Stanley Smith Barney LLC Executive Financial Services","unitsToSell":20000,"aggregateMarketValue":1324400,"unitsOutstanding":94261082,"approxSaleDate":"2026-09-10","exchange":"NASDAQ","filedAt":"2026-09-10","canonicalUrl":"https://xoomar.com/markets/stocks/tvtx"},{"accessionNo":"0001950047-26-008327","issuerCik":"0001438533","issuerName":"TRAVERE THERAPEUTICS, INC.","ticker":"TVTX","personName":"GARY LYONS","relationship":"Director","securityClass":"Common","broker":"Morgan Stanley Smith Barney LLC Executive Financial Services","unitsToSell":5000,"aggregateMarketValue":317650,"unitsOutstanding":94261082,"approxSaleDate":"2026-08-18","exchange":"NASDAQ","filedAt":"2026-08-18","canonicalUrl":"https://xoomar.com/markets/stocks/tvtx"},{"accessionNo":"0001950047-26-008242","issuerCik":"0001438533","issuerName":"TRAVERE THERAPEUTICS, INC.","ticker":"TVTX","personName":"GARY A LYONS","relationship":"Director","securityClass":"Common","broker":"Morgan Stanley Smith Barney LLC Executive Financial Services","unitsToSell":5000,"aggregateMarketValue":310700,"unitsOutstanding":94261082,"approxSaleDate":"2026-08-17","exchange":"NASDAQ","filedAt":"2026-08-17","canonicalUrl":"https://xoomar.com/markets/stocks/tvtx"},{"accessionNo":"0001376043-26-000007","issuerCik":"0001438533","issuerName":"Travere Therapeutics, Inc.","ticker":"TVTX","personName":"Coughlin Timothy","relationship":"Director","securityClass":"Common","broker":"Wells Fargo Clearing Services","unitsToSell":10000,"aggregateMarketValue":500429.72,"unitsOutstanding":92992905,"approxSaleDate":"2026-06-12","exchange":"Nasdaq","filedAt":"2026-06-12","canonicalUrl":"https://xoomar.com/markets/stocks/tvtx"},{"accessionNo":"0001950047-26-005979","issuerCik":"0001438533","issuerName":"TRAVERE THERAPEUTICS, INC.","ticker":"TVTX","personName":"ROY BAYNES","relationship":"Director","securityClass":"Common","broker":"Morgan Stanley Smith Barney LLC Executive Financial Services","unitsToSell":4500,"aggregateMarketValue":225000,"unitsOutstanding":92992905,"approxSaleDate":"2026-06-12","exchange":"NASDAQ","filedAt":"2026-06-12","canonicalUrl":"https://xoomar.com/markets/stocks/tvtx"},{"accessionNo":"0001376043-26-000004","issuerCik":"0001438533","issuerName":"Travere Therapeutics, Inc.","ticker":"TVTX","personName":"Coughlin Timothy","relationship":"Director","securityClass":"Common","broker":"Wells Fargo Clearing Services","unitsToSell":3250,"aggregateMarketValue":141182.59,"unitsOutstanding":92992905,"approxSaleDate":"2026-05-15","exchange":"Nasdaq","filedAt":"2026-05-15","canonicalUrl":"https://xoomar.com/markets/stocks/tvtx"},{"accessionNo":"0001959173-26-003306","issuerCik":"0001438533","issuerName":"Travere Therapeutics, Inc.","ticker":"TVTX","personName":"ROTE WILLIAM E.","relationship":"Officer","securityClass":"Common","broker":"Fidelity Brokerage Services LLC","unitsToSell":2763,"aggregateMarketValue":121433.85,"unitsOutstanding":92992905,"approxSaleDate":"2026-05-06","exchange":"NASDAQ","filedAt":"2026-05-06","canonicalUrl":"https://xoomar.com/markets/stocks/tvtx"},{"accessionNo":"0001950047-26-004101","issuerCik":"0001438533","issuerName":"TRAVERE THERAPEUTICS, INC.","ticker":"TVTX","personName":"ELIZABETH REED","relationship":"Officer","securityClass":"Common","broker":"Morgan Stanley Smith Barney LLC Executive Financial Services","unitsToSell":2076,"aggregateMarketValue":91240.2,"unitsOutstanding":92992905,"approxSaleDate":"2026-05-06","exchange":"NASDAQ","filedAt":"2026-05-06","canonicalUrl":"https://xoomar.com/markets/stocks/tvtx"},{"accessionNo":"0001950047-26-004100","issuerCik":"0001438533","issuerName":"TRAVERE THERAPEUTICS, INC.","ticker":"TVTX","personName":"JULA INRIG","relationship":"Officer","securityClass":"Common","broker":"Morgan Stanley Smith Barney LLC Executive Financial Services","unitsToSell":311,"aggregateMarketValue":13668.45,"unitsOutstanding":92992905,"approxSaleDate":"2026-05-06","exchange":"NASDAQ","filedAt":"2026-05-06","canonicalUrl":"https://xoomar.com/markets/stocks/tvtx"},{"accessionNo":"0001959173-26-003309","issuerCik":"0001438533","issuerName":"Travere Therapeutics, Inc.","ticker":"TVTX","personName":"Dube Eric M","relationship":"Officer","securityClass":"Common","broker":"Fidelity Brokerage Services LLC","unitsToSell":22500,"aggregateMarketValue":988875,"unitsOutstanding":92992905,"approxSaleDate":"2026-05-06","exchange":"NASDAQ","filedAt":"2026-05-06","canonicalUrl":"https://xoomar.com/markets/stocks/tvtx"},{"accessionNo":"0001950047-26-004102","issuerCik":"0001438533","issuerName":"TRAVERE THERAPEUTICS, INC.","ticker":"TVTX","personName":"CHRISTOPHER CLINE","relationship":"Officer","securityClass":"Common","broker":"Morgan Stanley Smith Barney LLC Executive Financial Services","unitsToSell":310,"aggregateMarketValue":13624.5,"unitsOutstanding":92992905,"approxSaleDate":"2026-05-06","exchange":"NASDAQ","filedAt":"2026-05-06","canonicalUrl":"https://xoomar.com/markets/stocks/tvtx"},{"accessionNo":"0001193125-26-207083","issuerCik":"0001438533","issuerName":"Travere Therapeutics, Inc.","ticker":"TVTX","personName":"Elizabeth E. Reed","relationship":"Officer","securityClass":"Common","broker":"Morgan Stanley Smith Barney","unitsToSell":2174,"aggregateMarketValue":101417.1,"unitsOutstanding":92992905,"approxSaleDate":"2026-05-05","exchange":"NASDAQ","filedAt":"2026-05-05","canonicalUrl":"https://xoomar.com/markets/stocks/tvtx"},{"accessionNo":"0001193125-26-207080","issuerCik":"0001438533","issuerName":"Travere Therapeutics, Inc.","ticker":"TVTX","personName":"Jula Inrig","relationship":"Officer","securityClass":"Common","broker":"Morgan Stanley Smith Barney","unitsToSell":2174,"aggregateMarketValue":101417.1,"unitsOutstanding":92992905,"approxSaleDate":"2026-05-05","exchange":"NASDAQ","filedAt":"2026-05-05","canonicalUrl":"https://xoomar.com/markets/stocks/tvtx"},{"accessionNo":"0001193125-26-207078","issuerCik":"0001438533","issuerName":"Travere Therapeutics, Inc.","ticker":"TVTX","personName":"Peter Heerma","relationship":"Officer","securityClass":"Common","broker":"Morgan Stanley Smith Barney","unitsToSell":2174,"aggregateMarketValue":101417.1,"unitsOutstanding":92992905,"approxSaleDate":"2026-05-05","exchange":"NASDAQ","filedAt":"2026-05-05","canonicalUrl":"https://xoomar.com/markets/stocks/tvtx"},{"accessionNo":"0001193125-26-207099","issuerCik":"0001438533","issuerName":"Travere Therapeutics, Inc.","ticker":"TVTX","personName":"Christopher Cline","relationship":"Officer","securityClass":"Common","broker":"Morgan Stanley Smith Barney","unitsToSell":2181,"aggregateMarketValue":101743.65,"unitsOutstanding":92992905,"approxSaleDate":"2026-05-05","exchange":"NASDAQ","filedAt":"2026-05-05","canonicalUrl":"https://xoomar.com/markets/stocks/tvtx"},{"accessionNo":"0001950047-26-004082","issuerCik":"0001438533","issuerName":"TRAVERE THERAPEUTICS, INC.","ticker":"TVTX","personName":"ROY BAYNES","relationship":"Director","securityClass":"Common","broker":"Morgan Stanley Smith Barney LLC Executive Financial Services","unitsToSell":4500,"aggregateMarketValue":209925,"unitsOutstanding":92992905,"approxSaleDate":"2026-05-05","exchange":"NASDAQ","filedAt":"2026-05-05","canonicalUrl":"https://xoomar.com/markets/stocks/tvtx"},{"accessionNo":"0001950047-26-003951","issuerCik":"0001438533","issuerName":"TRAVERE THERAPEUTICS, INC.","ticker":"TVTX","personName":"ELIZABETH REED","relationship":"Officer","securityClass":"Common","broker":"Morgan Stanley Smith Barney LLC Executive Financial Services","unitsToSell":20000,"aggregateMarketValue":900000,"unitsOutstanding":92241550,"approxSaleDate":"2026-05-04","exchange":"NASDAQ","filedAt":"2026-05-04","canonicalUrl":"https://xoomar.com/markets/stocks/tvtx"},{"accessionNo":"0001950047-26-003950","issuerCik":"0001438533","issuerName":"TRAVERE THERAPEUTICS, INC.","ticker":"TVTX","personName":"JEFFREY MECKLER","relationship":"Director","securityClass":"Common","broker":"Morgan Stanley Smith Barney LLC Executive Financial Services","unitsToSell":8000,"aggregateMarketValue":360000,"unitsOutstanding":92241550,"approxSaleDate":"2026-05-04","exchange":"NASDAQ","filedAt":"2026-05-04","canonicalUrl":"https://xoomar.com/markets/stocks/tvtx"},{"accessionNo":"0001950047-26-003946","issuerCik":"0001438533","issuerName":"TRAVERE THERAPEUTICS, INC.","ticker":"TVTX","personName":"JULA INRIG","relationship":"Officer","securityClass":"Common","broker":"Morgan Stanley Smith Barney LLC Executive Financial Services","unitsToSell":20000,"aggregateMarketValue":900000,"unitsOutstanding":92241550,"approxSaleDate":"2026-05-04","exchange":"NASDAQ","filedAt":"2026-05-04","canonicalUrl":"https://xoomar.com/markets/stocks/tvtx"},{"accessionNo":"0001950047-26-003899","issuerCik":"0001438533","issuerName":"TRAVERE THERAPEUTICS, INC.","ticker":"TVTX","personName":"ROY BAYNES","relationship":"Director","securityClass":"Common","broker":"Morgan Stanley Smith Barney LLC Executive Financial Services","unitsToSell":9750,"aggregateMarketValue":431145,"unitsOutstanding":92241550,"approxSaleDate":"2026-05-01","exchange":"NASDAQ","filedAt":"2026-05-01","canonicalUrl":"https://xoomar.com/markets/stocks/tvtx"},{"accessionNo":"0001959173-26-003030","issuerCik":"0001438533","issuerName":"Travere Therapeutics, Inc.","ticker":"TVTX","personName":"ROTE WILLIAM E.","relationship":"Officer","securityClass":"Common","broker":"Fidelity Brokerage Services LLC","unitsToSell":9100,"aggregateMarketValue":355719,"unitsOutstanding":92241550,"approxSaleDate":"2026-04-22","exchange":"NASDAQ","filedAt":"2026-04-22","canonicalUrl":"https://xoomar.com/markets/stocks/tvtx"},{"accessionNo":"0001950047-26-003482","issuerCik":"0001438533","issuerName":"TRAVERE THERAPEUTICS, INC.","ticker":"TVTX","personName":"ELIZABETH REED","relationship":"Officer","securityClass":"Common","broker":"Morgan Stanley Smith Barney LLC Executive Financial Services","unitsToSell":6785,"aggregateMarketValue":283823.34,"unitsOutstanding":92241550,"approxSaleDate":"2026-04-15","exchange":"NASDAQ","filedAt":"2026-04-15","canonicalUrl":"https://xoomar.com/markets/stocks/tvtx"},{"accessionNo":"0001950047-26-003477","issuerCik":"0001438533","issuerName":"TRAVERE THERAPEUTICS, INC.","ticker":"TVTX","personName":"JULA INRIG","relationship":"Officer","securityClass":"Common","broker":"Morgan Stanley Smith Barney LLC Executive Financial Services","unitsToSell":1018,"aggregateMarketValue":43376.98,"unitsOutstanding":92241550,"approxSaleDate":"2026-04-15","exchange":"NASDAQ","filedAt":"2026-04-15","canonicalUrl":"https://xoomar.com/markets/stocks/tvtx"},{"accessionNo":"0001959173-26-002926","issuerCik":"0001438533","issuerName":"Travere Therapeutics, Inc.","ticker":"TVTX","personName":"Dube Eric M","relationship":"Officer","securityClass":"Common","broker":"Fidelity Brokerage Services LLC","unitsToSell":64000,"aggregateMarketValue":2629832.99,"unitsOutstanding":92241550,"approxSaleDate":"2026-04-15","exchange":"NASDAQ","filedAt":"2026-04-15","canonicalUrl":"https://xoomar.com/markets/stocks/tvtx"},{"accessionNo":"0001950047-26-003478","issuerCik":"0001438533","issuerName":"TRAVERE THERAPEUTICS, INC.","ticker":"TVTX","personName":"CHRISTOPHER CLINE","relationship":"Officer","securityClass":"Common","broker":"Morgan Stanley Smith Barney LLC Executive Financial Services","unitsToSell":1014,"aggregateMarketValue":43206.54,"unitsOutstanding":92241550,"approxSaleDate":"2026-04-15","exchange":"NASDAQ","filedAt":"2026-04-15","canonicalUrl":"https://xoomar.com/markets/stocks/tvtx"},{"accessionNo":"0001950047-26-003425","issuerCik":"0001438533","issuerName":"TRAVERE THERAPEUTICS, INC.","ticker":"TVTX","personName":"ELIZABETH REED","relationship":"Officer","securityClass":"Common","broker":"Morgan Stanley Smith Barney LLC Executive Financial Services","unitsToSell":37500,"aggregateMarketValue":1540125,"unitsOutstanding":92241550,"approxSaleDate":"2026-04-14","exchange":"NASDAQ","filedAt":"2026-04-14","canonicalUrl":"https://xoomar.com/markets/stocks/tvtx"},{"accessionNo":"0001193125-26-155628","issuerCik":"0001438533","issuerName":"Travere Therapeutics, Inc.","ticker":"TVTX","personName":"Elizabeth E. Reed","relationship":"Officer","securityClass":"Common","broker":"Morgan Stanley Smith Barney","unitsToSell":7215,"aggregateMarketValue":302515.98,"unitsOutstanding":92241550,"approxSaleDate":"2026-04-14","exchange":"NASDAQ","filedAt":"2026-04-14","canonicalUrl":"https://xoomar.com/markets/stocks/tvtx"},{"accessionNo":"0001950047-26-003429","issuerCik":"0001438533","issuerName":"TRAVERE THERAPEUTICS INC","ticker":"TVTX","personName":"GARY A LYONS","relationship":"Officer","securityClass":"Common","broker":"Morgan Stanley Smith Barney LLC Executive Financial Services","unitsToSell":8000,"aggregateMarketValue":245600,"unitsOutstanding":92241550,"approxSaleDate":"2026-04-14","exchange":"NASDAQ","filedAt":"2026-04-14","canonicalUrl":"https://xoomar.com/markets/stocks/tvtx"},{"accessionNo":"0001193125-26-155560","issuerCik":"0001438533","issuerName":"Travere Therapeutics, Inc.","ticker":"TVTX","personName":"Jula Inrig","relationship":"Officer","securityClass":"Common","broker":"Morgan Stanley Smith Barney","unitsToSell":7215,"aggregateMarketValue":302515.98,"unitsOutstanding":92241550,"approxSaleDate":"2026-04-14","exchange":"NASDAQ","filedAt":"2026-04-14","canonicalUrl":"https://xoomar.com/markets/stocks/tvtx"},{"accessionNo":"0001193125-26-155537","issuerCik":"0001438533","issuerName":"Travere Therapeutics, Inc.","ticker":"TVTX","personName":"Peter Heerma","relationship":"Officer","securityClass":"Common","broker":"Morgan Stanley Smith Barney","unitsToSell":7215,"aggregateMarketValue":302515.98,"unitsOutstanding":92241550,"approxSaleDate":"2026-04-14","exchange":"NASDAQ","filedAt":"2026-04-14","canonicalUrl":"https://xoomar.com/markets/stocks/tvtx"},{"accessionNo":"0001950047-26-003426","issuerCik":"0001438533","issuerName":"TRAVERE THERAPEUTICS, INC.","ticker":"TVTX","personName":"CHRISTOPHER CLINE","relationship":"Officer","securityClass":"Common","broker":"Morgan Stanley Smith Barney LLC Executive Financial Services","unitsToSell":9,"aggregateMarketValue":369.63,"unitsOutstanding":92241550,"approxSaleDate":"2026-04-14","exchange":"NASDAQ","filedAt":"2026-04-14","canonicalUrl":"https://xoomar.com/markets/stocks/tvtx"},{"accessionNo":"0001193125-26-155495","issuerCik":"0001438533","issuerName":"Travere Therapeutics, Inc.","ticker":"TVTX","personName":"Christopher Cline","relationship":"Officer","securityClass":"Common","broker":"Morgan Stanley Smith Barney","unitsToSell":7239,"aggregateMarketValue":303522.27,"unitsOutstanding":92241550,"approxSaleDate":"2026-04-14","exchange":"NASDAQ","filedAt":"2026-04-14","canonicalUrl":"https://xoomar.com/markets/stocks/tvtx"},{"accessionNo":"0001950047-26-003416","issuerCik":"0001438533","issuerName":"TRAVERE THERAPEUTICS, INC.","ticker":"TVTX","personName":"SANDRA CALVIN","relationship":"Officer","securityClass":"Common","broker":"Morgan Stanley Smith Barney LLC Executive Financial Services","unitsToSell":21977,"aggregateMarketValue":902595.39,"unitsOutstanding":92241550,"approxSaleDate":"2026-04-14","exchange":"NASDAQ","filedAt":"2026-04-14","canonicalUrl":"https://xoomar.com/markets/stocks/tvtx"},{"accessionNo":"0001950047-26-003420","issuerCik":"0001438533","issuerName":"TRAVERE THERAPEUTICS, INC.","ticker":"TVTX","personName":"ROY BAYNES","relationship":"Director","securityClass":"Common","broker":"Morgan Stanley Smith Barney LLC Executive Financial Services","unitsToSell":32750,"aggregateMarketValue":1352130,"unitsOutstanding":92241550,"approxSaleDate":"2026-04-14","exchange":"NASDAQ","filedAt":"2026-04-14","canonicalUrl":"https://xoomar.com/markets/stocks/tvtx"},{"accessionNo":"0001193125-26-153378","issuerCik":"0001438533","issuerName":"Travere Therapeutics, Inc.","ticker":"TVTX","personName":"Christopher Cline","relationship":"Officer","securityClass":"Common","broker":"Morgan Stanley Smith Barney","unitsToSell":65,"aggregateMarketValue":1875.25,"unitsOutstanding":92241550,"approxSaleDate":"2026-04-13","exchange":"NASDAQ","filedAt":"2026-04-13","canonicalUrl":"https://xoomar.com/markets/stocks/tvtx"},{"accessionNo":"0001950047-26-003230","issuerCik":"0001438533","issuerName":"TRAVERE THERAPEUTICS, INC.","ticker":"TVTX","personName":"ROY BAYNES","relationship":"Director","securityClass":"Common","broker":"Morgan Stanley Smith Barney LLC Executive Financial Services","unitsToSell":10000,"aggregateMarketValue":330000,"unitsOutstanding":92241550,"approxSaleDate":"2026-04-06","exchange":"NASDAQ","filedAt":"2026-04-06","canonicalUrl":"https://xoomar.com/markets/stocks/tvtx"},{"accessionNo":"0001950047-26-003118","issuerCik":"0001438533","issuerName":"TRAVERE THERAPEUTICS, INC.","ticker":"TVTX","personName":"ELIZABETH REED","relationship":"Officer","securityClass":"Common","broker":"Morgan Stanley Smith Barney LLC Executive Financial Services","unitsToSell":10000,"aggregateMarketValue":300000,"unitsOutstanding":92241550,"approxSaleDate":"2026-04-01","exchange":"NASDAQ","filedAt":"2026-04-01","canonicalUrl":"https://xoomar.com/markets/stocks/tvtx"},{"accessionNo":"0001959173-26-002715","issuerCik":"0001438533","issuerName":"Travere Therapeutics, Inc.","ticker":"TVTX","personName":"Dube Eric M","relationship":"Officer, Director","securityClass":"Common","broker":"Fidelity Brokerage Services LLC","unitsToSell":60000,"aggregateMarketValue":1855654.74,"unitsOutstanding":92241550,"approxSaleDate":"2026-04-01","exchange":"NASDAQ","filedAt":"2026-04-01","canonicalUrl":"https://xoomar.com/markets/stocks/tvtx"},{"accessionNo":"0001950047-26-002635","issuerCik":"0001438533","issuerName":"TRAVERE THERAPEUTICS, INC.","ticker":"TVTX","personName":"ELIZABETH REED","relationship":"Officer","securityClass":"Common","broker":"Morgan Stanley Smith Barney LLC Executive Financial Services","unitsToSell":10000,"aggregateMarketValue":280861,"unitsOutstanding":92241550,"approxSaleDate":"2026-03-16","exchange":"NASDAQ","filedAt":"2026-03-16","canonicalUrl":"https://xoomar.com/markets/stocks/tvtx"},{"accessionNo":"0001959173-26-001307","issuerCik":"0001438533","issuerName":"Travere Therapeutics, Inc.","ticker":"TVTX","personName":"Dube Eric M","relationship":"Officer","securityClass":"Common","broker":"Fidelity Brokerage Services LLC","unitsToSell":60000,"aggregateMarketValue":1805765.69,"unitsOutstanding":92241550,"approxSaleDate":"2026-02-20","exchange":"NASDAQ","filedAt":"2026-02-20","canonicalUrl":"https://xoomar.com/markets/stocks/tvtx"},{"accessionNo":"0001950047-26-001339","issuerCik":"0001438533","issuerName":"TRAVERE THERAPEUTICS, INC.","ticker":"TVTX","personName":"ELIZABETH REED","relationship":"Officer","securityClass":"Common","broker":"Morgan Stanley Smith Barney LLC Executive Financial Services","unitsToSell":10000,"aggregateMarketValue":278317,"unitsOutstanding":89472327,"approxSaleDate":"2026-02-17","exchange":"NASDAQ","filedAt":"2026-02-17","canonicalUrl":"https://xoomar.com/markets/stocks/tvtx"},{"accessionNo":"0001950047-26-000918","issuerCik":"0001438533","issuerName":"TRAVERE THERAPEUTICS, INC.","ticker":"TVTX","personName":"ELIZABETH REED","relationship":"Officer","securityClass":"Common","broker":"Morgan Stanley Smith Barney LLC Executive Financial Services","unitsToSell":2994,"aggregateMarketValue":96360.09,"unitsOutstanding":89472327,"approxSaleDate":"2026-02-04","exchange":"NASDAQ","filedAt":"2026-02-04","canonicalUrl":"https://xoomar.com/markets/stocks/tvtx"},{"accessionNo":"0001950047-26-000917","issuerCik":"0001438533","issuerName":"TRAVERE THERAPEUTICS, INC.","ticker":"TVTX","personName":"JULA INRIG","relationship":"Officer","securityClass":"Common","broker":"Morgan Stanley Smith Barney LLC Executive Financial Services","unitsToSell":1779,"aggregateMarketValue":57299.1,"unitsOutstanding":89472327,"approxSaleDate":"2026-02-04","exchange":"NASDAQ","filedAt":"2026-02-04","canonicalUrl":"https://xoomar.com/markets/stocks/tvtx"},{"accessionNo":"0001193125-26-036557","issuerCik":"0001438533","issuerName":"Travere Therapeutics, Inc.","ticker":"TVTX","personName":"Peter Heerma","relationship":"Officer","securityClass":"Common","broker":"Morgan Stanley Smith Barney","unitsToSell":7310,"aggregateMarketValue":234799.04,"unitsOutstanding":89472327,"approxSaleDate":"2026-02-03","exchange":"NASDAQ","filedAt":"2026-02-04","canonicalUrl":"https://xoomar.com/markets/stocks/tvtx"},{"accessionNo":"0001950047-26-000904","issuerCik":"0001438533","issuerName":"TRAVERE THERAPEUTICS, INC.","ticker":"TVTX","personName":"CHRISTOPHER CLINE","relationship":"Officer","securityClass":"Common","broker":"Morgan Stanley Smith Barney LLC Executive Financial Services","unitsToSell":1745,"aggregateMarketValue":56165.62,"unitsOutstanding":89472327,"approxSaleDate":"2026-02-04","exchange":"NASDAQ","filedAt":"2026-02-04","canonicalUrl":"https://xoomar.com/markets/stocks/tvtx"},{"accessionNo":"0001959173-26-000560","issuerCik":"0001438533","issuerName":"Travere Therapeutics, Inc.","ticker":"TVTX","personName":"ROTE WILLIAM E.","relationship":"Officer","securityClass":"Common","broker":"Fidelity Brokerage Services LLC","unitsToSell":12446,"aggregateMarketValue":409100.02,"unitsOutstanding":89472327,"approxSaleDate":"2026-02-03","exchange":"NASDAQ","filedAt":"2026-02-03","canonicalUrl":"https://xoomar.com/markets/stocks/tvtx"},{"accessionNo":"0001193125-26-036479","issuerCik":"0001438533","issuerName":"Travere Therapeutics, Inc.","ticker":"TVTX","personName":"Elizabeth E. Reed","relationship":"Officer","securityClass":"Common","broker":"Morgan Stanley Smith Barney","unitsToSell":7175,"aggregateMarketValue":230463.88,"unitsOutstanding":89472327,"approxSaleDate":"2026-02-03","exchange":"NASDAQ","filedAt":"2026-02-03","canonicalUrl":"https://xoomar.com/markets/stocks/tvtx"},{"accessionNo":"0001193125-26-036456","issuerCik":"0001438533","issuerName":"Travere Therapeutics, Inc.","ticker":"TVTX","personName":"Jula Inrig","relationship":"Officer","securityClass":"Common","broker":"Morgan Stanley Smith Barney","unitsToSell":6956,"aggregateMarketValue":223429.38,"unitsOutstanding":89472327,"approxSaleDate":"2026-02-03","exchange":"NASDAQ","filedAt":"2026-02-03","canonicalUrl":"https://xoomar.com/markets/stocks/tvtx"},{"accessionNo":"0001959173-26-000570","issuerCik":"0001438533","issuerName":"Travere Therapeutics, Inc.","ticker":"TVTX","personName":"Dube Eric M","relationship":"Officer","securityClass":"Common","broker":"Fidelity Brokerage Services LLC","unitsToSell":100087,"aggregateMarketValue":3289859.69,"unitsOutstanding":89472327,"approxSaleDate":"2026-02-03","exchange":"NASDAQ","filedAt":"2026-02-03","canonicalUrl":"https://xoomar.com/markets/stocks/tvtx"},{"accessionNo":"0001193125-26-036459","issuerCik":"0001438533","issuerName":"Travere Therapeutics, Inc.","ticker":"TVTX","personName":"Christopher Cline","relationship":"Officer","securityClass":"Common","broker":"Morgan Stanley Smith Barney","unitsToSell":7242,"aggregateMarketValue":232616.03,"unitsOutstanding":89472327,"approxSaleDate":"2026-02-03","exchange":"NASDAQ","filedAt":"2026-02-03","canonicalUrl":"https://xoomar.com/markets/stocks/tvtx"},{"accessionNo":"0001193125-26-036474","issuerCik":"0001438533","issuerName":"Travere Therapeutics, Inc.","ticker":"TVTX","personName":"Sandra Calvin","relationship":"Officer","securityClass":"Common","broker":"Morgan Stanley Smith Barney","unitsToSell":4333,"aggregateMarketValue":139177.16,"unitsOutstanding":89472327,"approxSaleDate":"2026-02-03","exchange":"NASDAQ","filedAt":"2026-02-03","canonicalUrl":"https://xoomar.com/markets/stocks/tvtx"},{"accessionNo":"0001959173-26-000458","issuerCik":"0001438533","issuerName":"Travere Therapeutics, Inc.","ticker":"TVTX","personName":"Dube Eric M","relationship":"Officer","securityClass":"Common","broker":"Fidelity Brokerage Services LLC","unitsToSell":51865,"aggregateMarketValue":1560982.5,"unitsOutstanding":89472327,"approxSaleDate":"2026-01-27","exchange":"NASDAQ","filedAt":"2026-01-27","canonicalUrl":"https://xoomar.com/markets/stocks/tvtx"},{"accessionNo":"0001959173-26-000432","issuerCik":"0001438533","issuerName":"Travere Therapeutics, Inc.","ticker":"TVTX","personName":"Dube Eric M","relationship":"Officer, Director","securityClass":"Common","broker":"Fidelity Brokerage Services LLC","unitsToSell":8135,"aggregateMarketValue":244153.28,"unitsOutstanding":89472327,"approxSaleDate":"2026-01-23","exchange":"NASDAQ","filedAt":"2026-01-23","canonicalUrl":"https://xoomar.com/markets/stocks/tvtx"},{"accessionNo":"0001950047-26-000541","issuerCik":"0001438533","issuerName":"TRAVERE THERAPEUTICS, INC.","ticker":"TVTX","personName":"ELIZABETH REED","relationship":"Officer","securityClass":"Common","broker":"Morgan Stanley Smith Barney LLC Executive Financial Services","unitsToSell":10000,"aggregateMarketValue":273420,"unitsOutstanding":89472327,"approxSaleDate":"2026-01-20","exchange":"NASDAQ","filedAt":"2026-01-20","canonicalUrl":"https://xoomar.com/markets/stocks/tvtx"},{"accessionNo":"0001950047-26-000175","issuerCik":"0001438533","issuerName":"TRAVERE THERAPEUTICS, INC.","ticker":"TVTX","personName":"JULA INRIG","relationship":"Officer","securityClass":"Common","broker":"Morgan Stanley Smith Barney LLC Executive Financial Services","unitsToSell":445,"aggregateMarketValue":16798.75,"unitsOutstanding":89472327,"approxSaleDate":"2026-01-06","exchange":"NASDAQ","filedAt":"2026-01-06","canonicalUrl":"https://xoomar.com/markets/stocks/tvtx"},{"accessionNo":"0001193125-26-003062","issuerCik":"0001438533","issuerName":"Travere Therapeutics, Inc.","ticker":"TVTX","personName":"Jula Inrig","relationship":"Officer","securityClass":"Common","broker":"Morgan Stanley Smith Barney","unitsToSell":2031,"aggregateMarketValue":81605.58,"unitsOutstanding":89472327,"approxSaleDate":"2026-01-05","exchange":"NASDAQ","filedAt":"2026-01-05","canonicalUrl":"https://xoomar.com/markets/stocks/tvtx"},{"accessionNo":"0001959173-25-007916","issuerCik":"0001438533","issuerName":"Travere Therapeutics, Inc.","ticker":"TVTX","personName":"ROTE WILLIAM E.","relationship":"Officer","securityClass":"Common","broker":"Fidelity Brokerage Services LLC","unitsToSell":60000,"aggregateMarketValue":2406178.52,"unitsOutstanding":89472327,"approxSaleDate":"2025-12-24","exchange":"NASDAQ","filedAt":"2025-12-29","canonicalUrl":"https://xoomar.com/markets/stocks/tvtx"},{"accessionNo":"0001950047-25-010715","issuerCik":"0001438533","issuerName":"TRAVERE THERAPEUTICS, INC.","ticker":"TVTX","personName":"JULA INRIG","relationship":"Officer","securityClass":"Common","broker":"Morgan Stanley Smith Barney LLC Executive Financial Services","unitsToSell":15000,"aggregateMarketValue":630004.5,"unitsOutstanding":89472327,"approxSaleDate":"2025-12-24","exchange":"NASDAQ","filedAt":"2025-12-29","canonicalUrl":"https://xoomar.com/markets/stocks/tvtx"},{"accessionNo":"0001959173-25-007920","issuerCik":"0001438533","issuerName":"Travere Therapeutics, Inc.","ticker":"TVTX","personName":"Heerma Peter","relationship":"Officer","securityClass":"Common","broker":"Fidelity Brokerage Services LLC","unitsToSell":4980,"aggregateMarketValue":199200,"unitsOutstanding":89472327,"approxSaleDate":"2025-12-24","exchange":"NASDAQ","filedAt":"2025-12-29","canonicalUrl":"https://xoomar.com/markets/stocks/tvtx"},{"accessionNo":"0001950047-25-010713","issuerCik":"0001438533","issuerName":"TRAVERE THERAPEUTICS, INC.","ticker":"TVTX","personName":"SANDRA CALVIN","relationship":"Officer","securityClass":"Common","broker":"Morgan Stanley Smith Barney LLC Executive Financial Services","unitsToSell":7402,"aggregateMarketValue":296080,"unitsOutstanding":89472327,"approxSaleDate":"2025-12-24","exchange":"NASDAQ","filedAt":"2025-12-29","canonicalUrl":"https://xoomar.com/markets/stocks/tvtx"},{"accessionNo":"0001950047-25-010276","issuerCik":"0001438533","issuerName":"TRAVERE THERAPEUTICS, INC.","ticker":"TVTX","personName":"SANDRA CALVIN","relationship":"Officer","securityClass":"Common","broker":"Morgan Stanley Smith Barney LLC Executive Financial Services","unitsToSell":2910,"aggregateMarketValue":104760,"unitsOutstanding":89472327,"approxSaleDate":"2025-12-15","exchange":"NASDAQ","filedAt":"2025-12-15","canonicalUrl":"https://xoomar.com/markets/stocks/tvtx"},{"accessionNo":"0001950047-25-009511","issuerCik":"0001438533","issuerName":"TRAVERE THERAPEUTICS, INC.","ticker":"TVTX","personName":"CHRISTOPHER CLINE","relationship":"Officer","securityClass":"Common","broker":"Morgan Stanley Smith Barney LLC Executive Financial Services","unitsToSell":20000,"aggregateMarketValue":700200,"unitsOutstanding":89472327,"approxSaleDate":"2025-12-01","exchange":"NASDAQ","filedAt":"2025-12-01","canonicalUrl":"https://xoomar.com/markets/stocks/tvtx"},{"accessionNo":"0001950047-25-008434","issuerCik":"0001438533","issuerName":"TRAVERE THERAPEUTICS, INC.","ticker":"TVTX","personName":"SANDRA CALVIN","relationship":"Officer","securityClass":"Common","broker":"Morgan Stanley Smith Barney LLC Executive Financial Services","unitsToSell":67115,"aggregateMarketValue":2416140,"unitsOutstanding":89472327,"approxSaleDate":"2025-11-04","exchange":"NASDAQ","filedAt":"2025-11-04","canonicalUrl":"https://xoomar.com/markets/stocks/tvtx"},{"accessionNo":"0001959173-25-006629","issuerCik":"0001438533","issuerName":"Travere Therapeutics, Inc.","ticker":"TVTX","personName":"Heerma Peter","relationship":"Officer","securityClass":"Common","broker":"Fidelity Brokerage Services LLC","unitsToSell":5591,"aggregateMarketValue":195685,"unitsOutstanding":89472327,"approxSaleDate":"2025-10-31","exchange":"NASDAQ","filedAt":"2025-10-31","canonicalUrl":"https://xoomar.com/markets/stocks/tvtx"},{"accessionNo":"0001957799-25-000224","issuerCik":"0001438533","issuerName":"Travere Therapeutics, Inc.","ticker":"TVTX","personName":"Coughlin Timothy","relationship":"Director","securityClass":"common","broker":"Wells Fargo Clearing Services","unitsToSell":18000,"aggregateMarketValue":629693.48,"unitsOutstanding":89472327,"approxSaleDate":"2025-10-31","exchange":"Nasdaq","filedAt":"2025-10-31","canonicalUrl":"https://xoomar.com/markets/stocks/tvtx"},{"accessionNo":"0001959173-25-006603","issuerCik":"0001438533","issuerName":"Travere Therapeutics, Inc.","ticker":"TVTX","personName":"Dube Eric M","relationship":"Officer","securityClass":"Common","broker":"Fidelity Brokerage Services LLC","unitsToSell":27128,"aggregateMarketValue":817045.37,"unitsOutstanding":89138673,"approxSaleDate":"2025-10-29","exchange":"NASDAQ","filedAt":"2025-10-29","canonicalUrl":"https://xoomar.com/markets/stocks/tvtx"},{"accessionNo":"0001959173-25-006585","issuerCik":"0001438533","issuerName":"Travere Therapeutics, Inc.","ticker":"TVTX","personName":"Heerma Peter","relationship":"Officer","securityClass":"Common","broker":"Fidelity Brokerage Services LLC","unitsToSell":2662,"aggregateMarketValue":79860,"unitsOutstanding":89138673,"approxSaleDate":"2025-10-28","exchange":"NASDAQ","filedAt":"2025-10-28","canonicalUrl":"https://xoomar.com/markets/stocks/tvtx"},{"accessionNo":"0001959173-25-006592","issuerCik":"0001438533","issuerName":"Travere Therapeutics, Inc.","ticker":"TVTX","personName":"Dube Eric M","relationship":"Officer","securityClass":"Common","broker":"Fidelity Brokerage Services LLC","unitsToSell":92872,"aggregateMarketValue":2821217.14,"unitsOutstanding":89138673,"approxSaleDate":"2025-10-28","exchange":"NASDAQ","filedAt":"2025-10-28","canonicalUrl":"https://xoomar.com/markets/stocks/tvtx"},{"accessionNo":"0001950047-25-007388","issuerCik":"0001438533","issuerName":"TRAVERE THERAPEUTICS, INC.","ticker":"TVTX","personName":"ELIZABETH REED","relationship":"Officer","securityClass":"Common","broker":"Morgan Stanley Smith Barney LLC Executive Financial Services","unitsToSell":10000,"aggregateMarketValue":250000,"unitsOutstanding":89138673,"approxSaleDate":"2025-09-22","exchange":"NASDAQ","filedAt":"2025-09-22","canonicalUrl":"https://xoomar.com/markets/stocks/tvtx"}],"updatedAt":"2026-11-04T02:29:25.333Z","source":"xoomar.com","docs":"https://xoomar.com/markets/api","license":"https://xoomar.com/terms","attribution":"Credit XOOMAR with a link to the dataset page on xoomar.com when you republish this data","canonicalUrl":"https://xoomar.com/markets/stocks/tvtx","meta":{"source":"SEC","sourceAttribution":"Form 144 data: SEC.","notice":"10 requests a minute without a key, 30 with a free key. Get a free key at https://xoomar.com/signup?utm_source=api, register your app at https://xoomar.com/developers/register?utm_source=api, and credit the data as \"Data: XOOMAR\" together with the sourceAttribution line."}}